CorMedix Inc. — Director's Dealing 2026

Jan 27, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2026-01-26

Reporting Person: Lefkowitz Steven W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-26	Common Stock	A	30453	$0.00	Acquired	125951	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30152	Indirect
Common Stock	2000	Indirect

Footnotes

F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

F2: The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).